| miR-31 acts as an oncogenic miRNA (oncomir) in lung cancer by targeting specific tumor suppressors for repression. | lung, |
| miR-31 expression was significantly reduced in prostate cancer tissues, suggesting that miR-31 may act as tumor suppressor | prostate, |
| The findings provide strong evidence to support miR-31 as a new nasopharyngeal carcinoma-associated tumor suppressor on 9p21.3 region. | nasopharyngeal,laryngeal, |
| Loss of tumor suppressive microRNA-31 enhances TRADD/NF-?B signaling in glioblastoma | glioblastoma, |
| miR-31 is a tumor suppressor and SGPP2 and Smad4 are novel targets of miR-31, linking to STAT3 for regulating cancer cell proliferation, apoptosis and migration in gastric cancer. | gastric, |
| MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin ?5 | bladder, |
| MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR | lung, |
| miR-31-5p acted as a tumor suppressor to regulate SP1, miR-31-5p could be used as a therapeutic target for the treatment ofhepatocellular carcinoma. | liver, |
| MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1) | kidney, |
| MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. | lung, |
| miR-31 acts as an oncogenic miRNA (oncomir) in lung cancer by targeting specific tumor suppressors for repression. | lung, |
| The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer. | colorectal, |
| we found that miR-31 acts as an oncogene in colon cancer and identified RhoBTB1 as a new target of miR-31 further study demonstrated that miR-31 contributed to the development of colon cancer at least partly by targeting RhoBTB1. | colorectal, |
| MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). | colorectal, |
| The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31. | breast, |
| microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway. | endometrial, |
| Our results suggested that miR-31 plays an oncogenetic role in the development and progression of cervical cancer | cervical, |
| miR-31 functions as an oncogene in cervical cancer. | cervical, |
| Study demonstrated that miR-31 overexpression undertook an oncogenic role in esophageal squamous cell carcinoma (ESCC) by repressing the expression of LATS2 via the Hippo Pathway and activating epithelial-mesenchymal transition. | esophageal, |
| LOC554202 increased Laryngeal squamous cell carcinoma (LSCC) cell growth, cell cyle and cell invasion through suppressing miR-31 expression. These results suggested that LOC554202 acted as an oncogene in the development of LSCC. | laryngeal, |